- Home
- MVST vs XBIT Comparison
MVST vs XBIT Comparison
Compare MVST & XBIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MVST
- XBIT
- Stock Information
- Founded
- MVST 2006
- XBIT 2005
- Country
- MVST United States
- XBIT United States
- Employees
- MVST N/A
- XBIT N/A
- Industry
- MVST Industrial Machinery/Components
- XBIT Pharmaceuticals and Biotechnology
- Sector
- MVST Miscellaneous
- XBIT Health Care
- Exchange
- MVST Nasdaq
- XBIT Nasdaq
- Market Cap
- MVST 182.8M
- XBIT 194.5M
- IPO Year
- MVST N/A
- XBIT 2015
- Fundamental
- Price
- MVST $2.20
- XBIT $3.75
- Analyst Decision
- MVST Buy
- XBIT
- Analyst Count
- MVST 3
- XBIT 0
- Target Price
- MVST $3.33
- XBIT N/A
- AVG Volume (30 Days)
- MVST 18.3M
- XBIT 84.7K
- Earning Date
- MVST 11-12-2024
- XBIT 03-14-2025
- Dividend Yield
- MVST N/A
- XBIT N/A
- EPS Growth
- MVST N/A
- XBIT N/A
- EPS
- MVST N/A
- XBIT N/A
- Revenue
- MVST $370,989,000.00
- XBIT N/A
- Revenue This Year
- MVST $19.19
- XBIT N/A
- Revenue Next Year
- MVST $29.35
- XBIT N/A
- P/E Ratio
- MVST N/A
- XBIT N/A
- Revenue Growth
- MVST 39.03
- XBIT N/A
- 52 Week Low
- MVST $0.15
- XBIT $3.51
- 52 Week High
- MVST $2.87
- XBIT $9.96
- Technical
- Relative Strength Index (RSI)
- MVST 55.61
- XBIT 33.08
- Support Level
- MVST $1.92
- XBIT $3.60
- Resistance Level
- MVST $2.30
- XBIT $4.00
- Average True Range (ATR)
- MVST 0.27
- XBIT 0.26
- MACD
- MVST -0.06
- XBIT 0.07
- Stochastic Oscillator
- MVST 30.00
- XBIT 16.82
About MVST Microvast Holdings Inc.
Microvast Holdings Inc is a technology innovator that designs, develops, and manufactures lithium-ion battery solutions. It is renowned for its cutting-edge cell technology and its vertical integration capabilities which extend from core battery chemistry to battery packs.
About XBIT XBiotech Inc.
XBiotech Inc is a United States-based clinical-stage biopharmaceutical company. It is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-IL-1 a therapeutic antibody as a treatment for cancer. Geographically, all of its operations are in the United States.